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’INTRODUCTION
Receptor tyrosine kinases (RTKs) are cell surface receptors
endowedwithintrinsic proteintyrosinekinaseactivity. RTKsplay
pivotal roles in the regulation of many fundamental cellular
processes including cell cycle, metabolism, survival, cell prolifera-
tion and diﬀerentiation.
1 3 Unregulated RTK activities often
result in the genesis of many malignancies. In a typical RTK
pathway, upon binding of the ligand, the receptor becomes
activated by tyrosine autophosphorylation, which leads to recruit-
mentandactivationofavarietyofdownstreamtargetproteinsand
subsequent initiation of signaling cascades.
1 3
In recent years, large scale quantitative phosphoproteomics
based on mass spectrometry (MS) has emerged as a powerful
tool to study intracellular signal transduction through unbiased
comparison of protein phosphorylation in diﬀerent cellular
conditions.
4 6 In particular, for RTK pathways, quantitative
phosphoproteomic approaches can provide very informative
data because of the central roles of reversible phosphorylation
in RTK mediated signal transduction.
5,7
Currently there are three global phosphoproteomic approaches
that are most commonly used: (1) global phosphopeptide analysis
(phosphoserine/phosphothreonine/phosphotyrosine, or pSTY pep-
tide analysis),
8 11 (2) phosphotyrosine (pY) peptide analysis
9,12 17
and (3) pY protein analysis.
18 26 In a pSTY peptide analysis, all
three forms of phosphorylation (pS, pT and pY) between diﬀerent
experimental conditions are compared. Phosphorylated peptides
are isolated from protein digests, usually by immobilized metal
aﬃnity chromatography (IMAC)
27 or titanium dioxide (TiO2),
28
prior to MS analysis. Typically in these experiments very few pY
peptides are identiﬁed due to the relatively low frequency of
tyrosine phosphorylation. In a pY peptide analysis, only pY
peptidesareanalyzed.Anti-pYantibodiesareused toisolatepY
peptides from protein digests.
29 In a pY protein analysis,
quantitation is reported at the protein level rather than pep-
tide/phosphosite level, even though it is measured at the
peptide level. pY proteins and associated proteins are isolated
by anti-pY protein immunoprecipitation (IP) and the IPed
proteins are then identiﬁed and quantiﬁed by MS to determine
t h e i rr e l a t i v ea b u n d a n c ei nt h eI P .
18
Of the three strategies, the pSTY peptide analysis strategy, in
principle,canprovidethemostinformativedatabecauseitallows
comparison of all three forms of phosphosites. Recent advances
in phosphopeptide enrichment and MS detection techniques
have made it possible to identify thousands, or even tens of
thousands, of phosphosites.
28,30 Thus it appears that this should
be the method of choice to study RTK signaling. However, a
major concern of this strategy is that identiﬁcation of pY sites is
more diﬃcult than pS and pT sites because of relative low
abundance of pY peptides. The pY peptide analysis strategy is
designed to focus on only pY sites, and therefore provides better
coverage of pY sites than the pSTY strategy. Unlike the other
two strategies, the pY protein strategy does not provide quanti-
tative information about speciﬁc phosphosites. However, the
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pY protein analysis strategy is proven to be eﬃcient in detecting
protein eﬀectors in RTK pathways.
18 26 In principle it allows
identiﬁcation of interacting proteins that co-IP with pY proteins,
which is an advantage over the other two approaches.
While all three strategies have been successfully used to study
variousRTKpathways,toourknowledgetherehasbeennostudy
so far in the literature that compares them in terms of their
abilitiestoelucidatethemolecularbasisofRTKsignaling.Thusit
remains unclear whether one strategy generates signiﬁcantly
more informative data than another. In previous reported global
phosphoproteomic studies on RTK signaling, usually only a
single one of the three strategies was used in each study. The
choice of method was often determined by researcher’s famil-
iarity with speciﬁc techniques rather than inherent merits and
limitations of the diﬀerent strategies.
Inthisstudy,weattempttoassesstheutilityofthethreestrategies
in RTK signaling studies by using EphB receptor signaling as an
example. The Eph receptors form the largest group of RTKs.
They are involved in many important biological processes
including axon guidance, cell migration, tissue patterning, angio-
genesis and cancer.
31 EphB receptors are typical RTKs. They are
transmembrane receptors with extracellular ligand binding do-
mains and intracellular tyrosine kinase domains. In a previous
study, we used the pY protein analysis strategy to screen for
eﬀector proteins that are regulated by EphB receptors upon
ligand binding.
32 In the current study, we performed pSTY and
pY peptide analyses using the same cell line and treatment
conditions. The results obtained from the three analyses were
then compared to evaluate the strengths and limitations of the
diﬀerent strategies for studying RTK signaling.
’MATERIALS AND METHODS
SILAC Cell Culture and Ephrin Stimulation
Metabolic labeling and stimulation of cells were performed as
previouslydescribedwithminormodiﬁcations.
32Brieﬂy,NG108
cells (mouse neuroblastoma and rat glioma hybrid) stably over-
expressing the EphB2 receptor were diﬀerentially labeled in
medium containing either normal or heavy labeling amino acids.
ForthepSTYpeptideandpYproteinanalyses,
13C6arginineand
13 C6 lysine (Cambridge Isotope Laboratories, Andover, MA)
were used as the heavy amino acids. For the pY peptide analysis,
13 C9
15N1 tyrosine (Cambridge Isotope Laboratories, Andover,
MA) was used. After complete labeling, the cells were serum
starved for 24 h. One cell population was treated for 45 min with
2 μg/mL ephrinB1-Fc (Sigma-Aldrich) aggregated with anti-Fc
IgG (Jackson Immunoresearch) while the other population was
treated with anti-Fc IgG aggregated Fc as a control. For each cell
condition, about 100 million cells were used for the pY peptide
and pY protein analyses and about 20 million for the pSTY
peptide analysis to enable reasonable comparisons due to the
muchlowerabundanceofpYsites.Cellswerelysedinlysisbuﬀer
containing 1% Triton X-100, 150 mM NaCl, 20 mM Tris, pH 8,
0.2 mM ethylene diamine tetraacetic acid (EDTA), 2 mM
Na3VO4, 2 mM NaF, and protease inhibitors (Complete tablet;
Roche, Mannheim, Germany). The “light” and “heavy” lysates
were mixed in a 1:1 ratio (v:v) before subsequent handling.
Tryptic Digestion
For the pSTY peptide analysis, the lysate was precipitated
overnight at  20 C by addition of four volumes of ice-cold
acetone. Following centrifugation, precipitated proteins were
redissolved in 5% SDS and separated by SDS polyacrylamide
gel electrophoresis (SDS-PAGE). The gel was cut into 19 slices
forin-geldigestionwithtrypsinasdescribedpreviously.
32Brieﬂy,
the proteins in gel were reduced with DTT, alkylated with iodoace-
tylamideandincubatedwith12.5ng/μLtrypsin(PromegaCorpora-
tion, Madison, WI) in 25 mM ammonia bicarbonate overnight. The
resulting peptides were extracted twice with 5% formic acid/50%
acetonitrile and once with pure acetonitrile before the extract was
dried in a SpeedVac.
For thepY peptideanalysis, it wasnotnecessaryto fractionate
the proteins before digestion because of the relatively small
number of pY peptides in the sample (<1000). Therefore, the
“tube-gel” approach was used to isolate proteins from the whole
celllysatebyﬁrstimmobilizingtheproteininpolyacrylamidegels
during polymerization and then washing the gels extensively.
33
A 7.5% polyacrylamide gel was casted with the lysate: the lystate
was mixed with 30% acrylamide/N,N0-methylene-bis-acryla-
mide, tetramethylethylenediamine (TEMED) and 10% ammo-
nium persulfate and allowed to polymerize at room temperature
for 4 h. The gel was then washed extensively with 40% ethanol/
7% acetic acid prior to in-gel digestion using the procedure
described above.
Enrichment of Phosphopeptides using TiO2
Peptides werereconstitutedin5%triﬂuoroaceticacid(TFA)/
60% acetonitrile, incubated with 1 mg of TiO2 beads (GL
Sciences, Inc. Japan) with rotation for 1 h at room temperature.
The TiO2 beads were washed once with 5% TFA/80% acetoni-
trile, twice with 5% TFA/30% acetonitrile and once with 0.1%
TFA/30% acetonitrile. Phosphopeptides were eluted from the
beads by incubation with 1% ammonia hydrate (pH 10, diluted
from a 28% ammonia water solution) at room temperature for
5 min. The eluted peptides were desalted using C18 StageTips
34
prior to liquid chromatography-tandem mass spectrometry
(LC-MS/MS) analysis. To improve recovery of the enrichment,
the supernatant from the ﬁrst round of TiO2 enrichment was
subsequently incubated with fresh TiO2 beads one more time,
and the peptides from the second enrichment were analyzed by
LC MS/MS as well.
Anti-pY Peptide IP
Peptides from the in-gel digestion were reconstituted in
50 mM Tris-HCl pH 8.0. The anti-pY antibody 4G10
(Millipore) was used to pull down pY peptides from the digest.
We compared the performance of three commercial anti-pY
antibodies: 4G10, PY99 (Santa Cruz Biotechnology, Santa Cruz,
CA) and PY100 (Cell Signaling Technology) and found that
4G10 worked better than the other two antibodies for this
application (data not shown). The antibody was coupled to
protein G agarose beads (Roche) at 4 mg antibody per ml beads
byincubationovernightat4Cwithrotation.Aftercoupling,the
beads were washed four times with 20 bead volumes of 50 mM
Tris-HClpH8.0.Coupledantibody(10μL,40μg)wasaddedto
the peptides for IP at 4 C overnight with rotation. We detected
no tryptic peptides from the antibody in the IP eluate or the IP
supernatant ﬂuid, suggesting digestion of the pY antibody by the
residual trypsin from the in-gel digestion was minimal. After IP
the beads were washed three times with 400 μL of 50 mM Tris-
HClpH8.0andtwicewith400μLofwater.Peptideswereeluted
twice from beads byincubationwith 20 μLof 0.2% TFA at room
temperature for10min.Elutedpeptideswere puriﬁedusing C18
StageTips
34 before LC MS/MS analysis.5456 dx.doi.org/10.1021/pr200697x |J. Proteome Res. 2011, 10, 5454–5462
Journal of Proteome Research ARTICLE
Anti-pY Protein IP
The mixed lysate was incubated with agarose-conjugated anti-
pY antibody PY99 (Santa Cruz Biotechnology, Santa Cruz, CA)
for 4 h, and the beads were washed 4 times with lysis buﬀer.
Precipitated proteins were eluted with a low pH buﬀer (pH 2)
containing 0.2% TFA/1% SDS. The eluates were neutralized
with 1 M ammonium bicarbonate and separated by SDS-PAGE
on a 7.5% Tris-HCl gel (Biorad). The gel was stained with
Coomassie Blue and the gel lanes were cut horizontally into 10
sections for in-gel tryptic digestion.
LC MS/MS
For all LC MS/MS analysis, an LTQ-Orbitrap hybrid mass
spectrometer (Thermo Fisher Scientiﬁc) equipped with a nano-
electrospray ionization source (Jamie Hill Instrument Services)
was used. An Eksigent nanoLC system (Eksigent Technologies)
equipped with a self-packed 100-μm   15-cm reverse phase
column(ReprosilC18,3μm,Dr. Maisch GmbH,Germany)was
coupled to the mass spectrometer. Peptides were eluted by a
gradientof 3 40% acetonitrile in0.1% formic acid over 150 min
at aﬂowrate of400 nL/min.Mass spectra were acquired indata-
dependent mode with one 60000 resolution MS survey scan by
the Orbitrap and up to eight MS/MS scans in the LTQ for the
most intense peaks selected from each survey scan. Automatic
gain control target value was set to 1000000 for Orbitrap survey
scans and 5000 for LTQ MS/MS scans. Survey scans were
acquired in proﬁle mode and MS/MS scans were acquired in
centroid mode.
Peptide Identification and Quantitation
The raw mass spectra ﬁles were processed using MaxQuant
35
software (version 1.0.13.8). Protein and peptide identiﬁcation
was performed using the Mascot search engine (version 2.2.1,
Matrix Science) by querying the concatenated forward and
reverse International Protein Index protein database, containing
55303 mouse and 39906 rat protein sequences and 175 com-
monly observed contaminants (in total 190768 sequences in-
cluding reverse and contaminant sequences). The minimum
required peptide length was 6 amino acids, and trypsin cleavage
speciﬁcity was applied with 2 missed cleavages allowed. Variable
modiﬁcations included phosphorylation (STY), oxidation (M)
and N-acetylation (protein N-term). Carbamidomethylation
(C) was set as ﬁxed modiﬁcation. Initially the maximum allowed
mass deviations for precursor and fragment ions were set to
20 ppm and 0.5 Da, respectively. The results of the database
search were further processed and statistically evaluated by
MaxQuant.For protein andpeptideidentiﬁcation, themaximum
proteinand peptide false discovery rates (FDR) were set to0.01.
In addition, posterior error probability for individual peptide
identiﬁcations was required to be below or equal to 0.1. For pY
proteinanalysis, proteins were considered identiﬁed with at least
two peptides (with one uniquely assigned to the respective
sequence).
Bioinformatics
To ﬁnd statistically signiﬁcantly overrepresented gene ontol-
ogy (GO) terms and motifs, DAVID
36 (the database for annota-
tion, visualization and integrated discovery, version 6.7) online
function annotation tool was used. For the motif analysis, the
SMART database was used.
37 A probability value of 0.05 was
considered as signiﬁcant.
FormappingproteinstoKEGGpathways,theKEGGMapper
(version 1.0) was used.
38 For retrieving protein interactions and
constructingproteininteractionnetworks,theSTRINGdatabase
(version 8.3) was used.
39
’RESULTS AND DISCUSSION
SILAC Analysis of EphB Signaling using Three Phosphopro-
teomic Strategies
In this study, we performed SILAC experiments to quantify
changes inphosphorylationcausedbyactivation of Ephreceptor
signaling. The workﬂow of the experiments is shown in Figure 1.
For protein and peptide quantitation, we used stable isotope
labeling with amino acids in cell culture (SILAC).
40 One
advantage of SILAC is that it allows combining of diﬀerentially
labeled protein samples early on during sample preparation.
41
This is especially important for the experiments in this study
because several sample fractionation and enrichment steps were
involved.
ForthepSTYpeptide analysis,two biological SILAC replicate
analyses were performed on phosphopeptides enrichedby TiO2.
From the two replicates, 5771 sites were quantiﬁed by Max-
Quant. These sites correspond to 3854 peptides from 2086
proteins. 4809 phosphosites were class I sites (>75% localization
probability).TherelativeoccurrenceofclassIpS,pTandpYsites
were 82%, 17% and 1% respectively. SILAC ratios from the two
replicateanalyseswereconsistent,indicatinghighreproducibility
of the analysis (Supplementary Figure 1A, Supporting In-
formation). Supplementary Table 1 (Supporting Information)
lists all of the quantiﬁed phosphorylation sites. Figure 2A shows
the SILAC ratios of quantiﬁed phosphopeptides. Using 1.5 fold
astheSILACratiocutoﬀ(correspondingtoP<0.02ascalculated
by MaxQuant that the quantities are diﬀerent by chance), 513
phosphorylation sites had changed SILAC ratios upon ephrinB1
treatment: 220 sites were up-regulated and 293 down-regulated.
For the regulated phosphorylation sites, the relative occurrence
Figure 1. Overview of the workﬂow for using three phosphoproteomic
strategies to study EphB signaling. NG108-EphB2 cells were labeled
with SILAC. The ephrinB1 ligand treated and untreated cells were
combined for each of the three analyses. For each cell condition,
approximately 100 million cells were used for the pY peptide/protein
analysis and about 20 million for the pSTY peptide analysis. The total
mass spectrometry analysis time was 95, 2.5, and 20 h for the pSTY
peptide, pY peptide and pY protein analysis, respectively.5457 dx.doi.org/10.1021/pr200697x |J. Proteome Res. 2011, 10, 5454–5462
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of class I pS, pT and pY sites were 77, 17 and 6%. The relative
pS/pT/pY abundances for both the whole data set and the
regulated sites only are consistent with a previously published
study on EGF signaling.
8 The signiﬁcant enrichment of pY sites
in the regulated sites reﬂects the fact that pY sites were more
frequently regulated in EphB signaling than pS/pT sites.
For the pY peptide analysis, two biological SILAC replicates
wereperformedonpYpeptidesenrichedbyananti-pYantibody.
From this analysis, 703 phosphosites were quantiﬁed by Max-
Quant. These sites correspond to 609 peptides from 422
proteins. 628 sites were class I sites. Of these, 90% of phosphates
were localized to tyrosine, 4% on serine, and 6% on threonine,
though it is likely that some of the pS and pT assignments were
due to incorrect localization. As in the case of the pSTY analysis,
the results of the two biological replicates were highly correlated
(Supplementary Figure 1B, Supporting Information). Supple-
mentaryTable2(SupportingInformation)listsallthequantiﬁed
phosphorylation sites. Figure 2B shows the SILAC ratios of
quantiﬁed phosphopeptides. Using 1.5 fold as the SILAC ratio
cutoﬀ, 315 phosphorylation sites had changed SILAC ratios
upon EphrinB1 treatment. 287 of these sites were up-regulated,
28 down-regulated.
For the pY protein analysis, two replicates of pY protein
immunoprecipitatesfromephrinB1stimulatedandunstimulated
NG108-EphB2 cells were analyzed in a previously described
experiment.
32 In that study the data set was processed using
MSQuantsoftware.
42Inthecurrentstudywereanalyzedthisdata
set using MaxQuant so that the result can be compared with the
results of the pSTY peptide and pY peptide analyses. From the
two biological replicates, 872 proteins were quantiﬁed. The
SILAC ratios from the two replicates were consistent
(SupplementaryFigure1C,SupportingInformation).The ratios
by MaxQuant were consistent with those from our previous
result by MSQuant (Supplementary Figure 2, Supporting In-
formation). Figure 2C shows the SILAC ratios of quantiﬁed
proteins. Two-hundred eight proteins changed their abundance
by at least 1.5 fold: 195 proteins showed increased abundance in
pY IP and 13 proteins showed decreased abundance. A list of all
the quantiﬁed proteins is shown in Supplementary Information
Table 3 (Supporting Information). In this analysis, 124 phos-
phosites were identiﬁed. However, their SILAC ratios cannot be
attributed to site-speciﬁc phosphorylation changes because the
phosphopeptide ratios could depend on other pY sites on the
protein or on protein protein interactions, so these phospho-
sites were not used for further analysis.
One potential concern for quantitative phosphoproteomics is
that changes in protein expression can aﬀect phosphopeptide/
phosphoproteinratios. In our SILAC analyses, we used the same
cell line under the same growing conditions. The only diﬀerence
between the two samples was that one set of cells was treated
withephrinB1-Fc for 45 minandthe other set of cells was mock-
treated with Fc. The time of treatment was short and thus we
reasoned it would not lead to signiﬁcant changes in protein
expression. To experimentally conﬁrm this, we analyzed the
mixed SILAC cell lysate to compare protein abundance before
and after the ephrinB1 treatment. We also quantiﬁed proteins
identiﬁed from the TiO2 enrichment experiments using only
nonphosphorylated peptides. These two analyses resulted in
quantitation of 869 proteins and none of them showed a change
in abundance greater than 1.5 fold (Supplementary Figure 3,
Supporting Information).
Tobeabletocomparethethreephosphoproteomicstrategies,
it is important for the analyses to have similar coverage of the
phosphoproteome. We identiﬁed a reasonably large number of
phosphosites/proteins from each SILAC analysis,which allowed
us to perform statistical analysis to compare the diﬀerent
strategiesfrommultipleangles.Meanwhile,thislevelofanalytical
depth should be achievable by many proteomic laboratories that
are equipped with similar instrumentation (which is becoming
more and more accessible) with reasonable eﬀorts. In that sense,
the results from this study should be applicable to a broad range
of analytical laboratories.
SILAC Ratio Distribution
When comparing the SILAC ratio distribution of the three
analyses, one interesting observation is that the proportion of
SILAC outliers (>1.5 fold changes in SILAC ratio) diﬀered
considerably among the three analyses (Figure 3A). About 9,
45 and 24% of phosphosites/proteins quantiﬁed from the pSTY
peptide, pY peptide and pY protein analysis, respectively, were
outliers. This means that the probability of a pY site being
regulated by EphB receptor upon ligand binding was roughly 5
times (45/9) higher than those of pS/pT sites. This reﬂects the
dramatic diﬀerences in the eﬃciency to detect changes in the
RTK signaling by the three strategies. The pY protein analysis
had considerably lower outlier percentage than the pY peptide
analysis, possibly because of the presence of nonspeciﬁc binding
proteins in pY protein IP. However, it is diﬃcult to estimate the
number of nonspeciﬁc binding proteins in a pY IP experiment.
Another interesting observation is that a considerable propor-
tion of regulated sites detected in the pY peptide analysis were
detected at high abundance, whereas regulated sites detected by
the pSTY peptide experiment were mostly of low to medium
abundance(Figure3B).Theabundanceherereferstoabundance
of analyte in the prepared samples for MS after aﬃnity puriﬁca-
tion, not the original abundance in the cell. This result is not
surprising because it is well-known that a large number of pS/pT
sites reside on highly abundant structural/metabolic proteins and
thesesitesaregenerallynotsigniﬁcantlyregulatedbyRTKsignaling.
Figure2. (A)SILACratios ofpSTYpeptides,(B)pYpeptides and(C)
pY proteins. Normalized phosphopeptide ratios (in A and B) or protein
ratios (in C) are plotted against summed peptide or protein intensities.5458 dx.doi.org/10.1021/pr200697x |J. Proteome Res. 2011, 10, 5454–5462
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Incontrast,highlyphosphorylatedtyrosinesitesareoftenkeytargets
of modulation in RTK signal transduction. The implication of this
phenomenonforMSanalysisisthatingeneralregulatedpYsitesare
identiﬁed and quantiﬁed with higher conﬁdence than pS/pT sites
because higher signaling intensity in MS leads to better qualitative
and quantitative results.
We also observed that for the regulated phosphosites or
proteins, the SILAC ratios were in general signiﬁcantly more
diﬀerent from one in the pY peptide/protein analysis than in the
pSTYpeptideanalysis.ThisisconsistentwithpYsitesbeingmore
tightly controlled than pS/pT sites at basal levels. Figure 3C also
shows that SILAC ratios were more signiﬁcantly diﬀerent from
oneinthepYproteinanalysisthaninthepYpeptideanalysis.This
suggests that in a pY protein IP, the binding aﬃnity increases
nonlinearly with simultaneous increase of tyrosine phosphoryla-
tion levels on multiple pY sites, that is, small changes of tyrosine
phosphorylation on multiple sites on a protein can lead to a big
change in the protein’sp YI Pe ﬃciency. This ampliﬁcation eﬀect
makes it easier todistinguish somesigniﬁcantlyregulatedproteins
from unchanged ones by using the pY protein strategy.
Overlap in Phosphosite Identification
ThepSTYandpYpeptideexperiments hadvery smalloverlap
in phosphosite identiﬁcation. The two analyses identiﬁed 6445
phosphosites in total, while only 0.4% of them were identiﬁed in
both analyses (Supplementary Figure 4A, Supporting In-
formation). When only regulated phosphosites are considered,
2%ofthesiteswereidentiﬁedinboth(SupplementaryFigure4B,
Supporting Information). The small overlap was a result of both
the high speciﬁcity of the pY peptide analysis for detecting pY
sites and the ineﬃciency of the pSTY peptide analysis for
detecting pY sites. The diﬃculty to detect pY sites by the pSTY
peptide strategy is due to the fact that the TiO2 enriched peptide
mixtures are dominated by pS and pT peptides, which aﬀects
detection of the much less abundant pY peptides. It should be
noted that the pSTY experiment used 5 times less starting
material than the pY peptide experiment. However, even if more
material were used with more extensive sample fractionation, it
would be still diﬃcult for the pSTY peptide analysis to identify a
comparablenumberofpYsites(∼700)becauseonly∼1%ofthe
identiﬁedsites wereon tyrosine residues intheTiO2enrichment
experiment. This means that to identify 700 pY sites, one would
need to identify ∼70000 total phosphosites. But to our knowl-
edge, the most comprehensive pSTY peptide analysis with
SILAC so far in the literature identiﬁed 20443 phosphosites.
28
ThisindicatesthatourpYpeptideanalysisachievedmuchgreater
analytical depth in pY site identiﬁcation than our pSTY peptide
analysis.ThereforethepSTYpeptideanalysisstrategycannotyet
replace the pY peptide analysis strategy for comprehensive
screening of pY sites.
Overlap in Protein Identification
A major goal of phosphoproteomic analysis of intracellular
signalingistoidentifyeﬀectorproteinsthatareinvolvedinsignal
transduction. To compare the abilities of the three strategies to
identify signaling eﬀectors, we compared the proteins that were
identiﬁed in the three SILAC experiments.
In total, 2866 proteins (all proteins from the pY protein
experiment and proteins from pSTY/pY peptide experiment
with identiﬁed phosphopeptides) were identiﬁed in the three
experiments(Figure4A).Only3%oftheproteinswereidentiﬁed
in all three experiments, 12% identiﬁed in two of the three
experiments and 85% identiﬁed in only one experiment. When
only the regulated proteins are considered, the overlap was even
smaller (Figure 4B). In total 660 potential eﬀector proteins were
identiﬁed. Two percent of eﬀector proteins were identiﬁed in all
three experiments, 10% in two experiments and 88% in only one
Figure 3. Comparison of SILAC ratio distributions. (A) SILAC ratio
histograms for all quantiﬁed phosphosites/proteins from the three
analyses. (B) Intensity histograms for changed phosphosites/proteins.
For the peptide analyses, peptide MS intensities were used. For the pY
protein analysis, protein intensity is calculated as summed peptide
intensity. The intensities in the pY peptide and pY protein analyses
are normalized to the pSTY peptide analysis based on median intensity.
Thedottedlineshowsthemedianintensityofallthreedatasets.(C)Box
plot of absolute ratio changes for the regulated peptides/proteins.
Figure 4. Overlap of proteins identiﬁed from the three analyses. (A) All proteins. (B) Proteins with >1.5 fold changes in SILAC ratio.5459 dx.doi.org/10.1021/pr200697x |J. Proteome Res. 2011, 10, 5454–5462
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experiment.Thisdegreeofoverlapismuchsmallerthantheoverlap
between replicatesof the same experimentfor each analysis (∼50%
for the pY peptide and pY protein analyses, > 60% for the pSTY
peptide analysis). Therefore the small overlap in protein identi-
ﬁcation by the three analyses was not a random event caused by
run-to-run variations. This suggests that the three strategies
preferentially target diﬀerent subsets of the phosphoproteome.
The pY peptide analysis and the pY protein analysis shared
more eﬀector proteins with each other than with the pSTY
peptide analysis, probably because they were both based on
detectingchangesintyrosinephosphorylation. Nevertheless, the
eﬀectorproteinsidentiﬁedinbothexperimentsonlyaccountsfor
14% of the total eﬀector proteins identiﬁed in the two experi-
ments. It was observed that in these two experiments SILAC
ratios for pY proteins and their pY sites were not always
consistent (Figure 5). A total of 206 proteins identiﬁed in the
pYproteinanalysishadphosphositesidentiﬁedinthepYpeptide
analysis. 49oftheseproteinshad unchangedproteinratios inthe
pY protein analysis but signiﬁcantly changed phosphosite ratios
in the pY peptide analysis. Conversely, 21 proteins with changed
proteinratios had nochangedphosphosite ratios asmeasuredby
the pY peptide analysis. These two types of proteins accounted
for 34% of all eﬀector proteins identiﬁed in both analyses,
suggesting that the pY peptide and pY protein analyses were
complementary in ﬁnding eﬀector proteins even though they are
both based on measuring tyrosine phosphorylation. The most
likely reasons are: (1) Diﬀerent phosphosites on the same
protein are regulated diﬀerently, sometimes in diﬀerent direc-
tions. The pY protein strategy is unable to identify eﬀector
proteins in cases where speciﬁc pY sites on a protein are
signiﬁcantly regulated, but this regulation does not lead to a
signiﬁcant change in the total pY level of the protein. For
example, Tubulin beta-3 chain (Tubb3) had a protein ratio of
1.0inthepYproteinanalysis.TwopYpeptidesfromthisprotein,
FWEVISDEHGIDPSGNY(ph)VGDSDLQLER and VSDTVV-
EPYNATLSIHQLVENTDETYCIDNEALY(ph)DICFR were
identiﬁed in the pY peptide analysis with signiﬁcant changes in
opposite directions (0.47 and 1.7, respectively). In that sense,
proteins with unchanged ratios in a pY protein analysis are not
always noneﬀectors. In such cases, a pY peptide analysis may
provide complementary information to determine if the protein
is involved in the signaling. (2) In a pY peptide analysis, usually
not all the pY sites on a protein are detectable by MS, due for
example, to location on very large or very small tryptic peptides.
But as long as the regulated sites cause a change in the overall pY
leveloftheprotein, itispossibletoidentifytheeﬀector withapY
protein analysis.
Overall, the pSTY peptide, pY peptide and pY protein experi-
ments contributed 40%, 20% and 23% of unique eﬀectors to the
combined result, respectively. This indicates that the three
experiments were very complementary in discovering eﬀector
proteins in the pathway.
GO Annotation/Domain Enrichment Analysis
To ﬁnd out which parts of the proteome the three diﬀerent
strategies prefer to detect, we performed gene ontology enrich-
ment analysis of the quantiﬁed proteins from each experiment
using all mouse proteins from the Swissprot database as the
background (Supplementary Table 4, Supporting Information).
The result shows that these three strategies enriched several
common GO categories, including cell junction, cytoskeleton
and protein transport. They also exhibited speciﬁc preferences
for enriching diﬀerent GO categories such as nucleus, DNA
binding, plasma membrane, translation and transcription. In
general, it seems that the pSTY peptide analysis showed pre-
ferencetowardimplicationofnuclearproteinsandDNAbinding
proteins, while the pY peptide and pY protein experiments
preferred proteins on or close to the cell surface.
To further conﬁrm this observation, we performed a domain
enrichment analysis (Supplementary Table 5, Supporting In-
formation). We observed that zinc ﬁnger domain (ZnF_C3H1),
whichisknowntobeinvolvedinprotein DNAinteractions,was
signiﬁcantly enriched by the pSTY peptide analysis but not the
other two. In contrast, SH2 and SH3 domains, which are well
characterized domains that are involved in signaling complex
assembly proximal to the plasma membrane in early RTK
signaling, are much more enriched by the pY peptide and pY
protein analyses. Thus the domain analysis results are consistent
with the GO analysis.
Last, we compared the ability of the three analyses to identify
several major categories of signaling proteins as eﬀector proteins
bycountingthenumbersoftheseproteinsthatwerequantiﬁedas
eﬀector proteins by each of the three analyses. These categories
include kinase, tyrosine kinase, transcription factor, GTPase,
adaptorprotein,G-proteincoupledreceptor,scaﬀoldproteinand
phosphatase. The result (Figure 6) shows that while the three
analyses performed similarly in some categories such as phos-
phatase, they diﬀered signiﬁcantly in others. The pSTY peptide
analysisidentiﬁedmanymoretranscriptionfactorsthantheother
two analyses. The exceptional ability of the pSTY strategy to
identifytranscriptionfactorsinourexperimentisalsoinlinewith
theresultfromapreviousstudyonEGFRsignaling.
8BoththepY
peptide and pY protein analyses identiﬁed two adaptor proteins
while the pSTY peptide analysis identiﬁed none. Moreover, the
pSTY analysis identiﬁed more kinases but fewer transmembrane
or membrane-associated tyrosine kinases than the other two
analyses.
Our GO annotation and domain enrichment analysis results
furthersupporttheideathatthethreestrategieshavepreferences
for detecting particular subsets of the phosphoproteome. It also
implies biological reasons for the lack of overlap between the
three strategies. RTK signaling is a sophisticated process which
involves temporal and spatial regulation of proteins on multiple
levels. In a typical scheme, in the early stage of signal processing,
Figure 5. Correlation of SILAC ratios between pY proteins (from the
pY protein experiment) and their pY sites (from the pY peptide
experiment).DatapointsinredrepresentcaseswheresigniﬁcantSILAC
ratios were observed in one experiment but not the other.5460 dx.doi.org/10.1021/pr200697x |J. Proteome Res. 2011, 10, 5454–5462
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RTK activation leads to recruitment of signaling mediators such
as adaptor proteins, for assembly of signaling complexes close to
the plasma membrane. Later the signal is transmitted spatially
from the cell surface toward diﬀerent cellular compartments.
Lastly, signaling proteins are translocated into the nucleus to
regulatetranscription,whicheventuallycauseschangesinprotein
expression. In the early stage, most signaling events, including
endocytosis,arehighlydependentontyrosinephosphorylation.In
later stages, serine and threonine phosphorylation gradually
becomes more important. This would explain our observation
that the pY peptide/pY protein strategies performed better in
identifying signaling proteins in early signaling events, such as
plasma membrane proteins and adaptor proteins, while the pSTY
peptidestrategyismoresuccessfulinidentifyingsignalingproteins
in late signaling events, such as transcription factors and nuclear
proteins.
Protein Interaction Networks
To ﬁnd out which strategy is more eﬃcient in detecting
protein interactions for the EphB pathway, we uploaded the
regulatedproteinsidentiﬁedinthethreeanalysestotheSTRING
protein interaction database to retrieve protein interactions for
each analysis. The output networks are shown in Supplementary
Figures 5, 6 and 7 (Supporting Information). It can be observed
that the pY peptide and pY protein analyses resulted in overall
more strongly connected interaction networks. Several subnet-
works, such as endocytosis (Supplementary Figure 7), cytoske-
letal regulation (Supplementary Figure 7), and protein
translation (Supplementary Figure 6), can be easily recognized
because the related proteins are tightly connected by high
conﬁdence interactions. By contrast, the pSTY peptide analysis
network is less tightly connected. The number of regulated
proteins from each analysis with documented interactions in
the STRING database was 325 for the pSTY peptide analysis,
187 for the pY peptide analysis and 196 for the pY protein
analysis. The number of interactions between these proteins was
305forthepSTYpeptideanalysis,308forthepYpeptideanalysis
and 269 for the pY protein analysis. Although the pSTY peptide
analysis generated more proteins with documented interactions
in the STRING database, the number of total interactions was
almostthesameasthepYpeptideanalysisandonlyslightlymore
than the pY protein analysis. Moreover, the pY peptide and
pY protein analyses both identiﬁed seven direct EphB receptor
interactors, while the pSTY analysis only identiﬁed three. Taken
together,theseresultssuggestthatthepYpeptideandpYprotein
analyses were more eﬃcient in detecting proteins in signaling
complexes.
Another observation is that the pY peptide analysis detected
slightly more protein interactions than the pY protein analysis. It
was somewhat unexpected that the pY protein analysis detected
fewerinteractionsthanthepYpeptideanalysis.Ithasbeenthought
that the pY protein strategy can detect binding partners of pY
proteins, which should translate into more protein interactions.
But our result suggests that the contribution of this mechanism to
eﬀector protein discovery may be more limited than previously
thought. A possible explanation is that many protein interactions
in RTK signaling are transient in nature and not properly main-
tainedduringpYIP.Itispossiblethatproteininteractionsthatare
dependent on pY sites can be disrupted by competitive binding
from anti-pY antibodies during an anti- pY IP.
Association of Regulated Proteins with Signaling Pathways
To determine which downstream pathways were regulated by
activation of the EphB receptor, the regulated proteins identiﬁed in
the three analyses were mapped to KEGG pathways. The mapping
was performed for each individual SILAC analysis and also the
combined result of all three analyses. The pathways that included at
least 15 proteins found in the combined protein list are shown in
Supplementary Figure 8 (Supporting Information). The best repre-
sentedpathwayscover mostof theknowndownstream pathways of
theEphBreceptor,whichincludeendocytosis,axonguidance,and
regulation of cytoskeleton, demonstrating the eﬃciency of our
SILAC experiments for detecting signal transduction networks.
The three analyses implicated more or less the same KEGG
pathways, suggesting that the diﬀerent approaches are able to
consistently detect the same signaling outcome. However, in some
pathways such as endocytosis and metabolic pathways, the three
approachesresultedinverydiﬀerentcoverageofcomponentproteins
inthenetworks.AlthoughthepSTYpeptideanalysiscontributedthe
highestnumberofregulatedproteins,thepYpeptideandpYprotein
analyses generated similar numbers of proteins mapped to most of
the pathways in Supplementary Figure 8 (Supporting Information).
The combined result identiﬁed more than twice as many mapped
proteins as each individual analysis (2.2 times as the pSTY peptide
analysis, 2.5 times as the pY peptide analysis and 2.0 times as the
pY protein analysis), which again underscores the fact that the three
strategies are highly complementary.
’CONCLUSIONS
We have assessed the performance of the pSTY peptide, pY
peptide and pY protein analysis strategies for RTK signaling
study using EphB signaling as an example. Our results show that
the three strategies are very complementary in providing infor-
mation about RTK pathways. Importantly, one strategy may be
more eﬃcient for some particular time points or locations in the
signaling pathway but less optimal for others. Recognition of
these characteristics of the strategies will allow researchers to
better choose the most eﬃcient strategy based on their speciﬁc
analytical goals.
Previous phosphoproteomic studies have used one of the
three phosphoproteomic strategies to investigate RTK signaling
pathways. Many of these studies chose to use the pY based
strategiesbecauseofthecentralroleoftyrosinephosphorylationin
RTK signal transduction. A major limitation of these strategies is
Figure6. Diﬀerentcategoriesofeﬀectorproteinsidentiﬁedbythethree
analyses. Only proteins with >1.5 fold changes in SILAC ratio are
considered.5461 dx.doi.org/10.1021/pr200697x |J. Proteome Res. 2011, 10, 5454–5462
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that they are unable to detect phosphorylation changes on serine
and threonine sites. Our results demonstrate that while the pY
based strategies indeed perform well in elucidating the signaling
networks that are spatially close to the receptor in early signaling
stages, a large population of pS/pT sites/proteins that are further
downstreamofthereceptorareundetectablebytheseapproaches.
The number of these pS/pT eﬀectors can be signiﬁcantly more
thanthepY eﬀectorsasshowninouranalysisoftheEphpathway.
Conversely, if the pSTY peptide analysis strategy is used alone,
detectionofchangesonpYsitesisgreatlycompromisedbecauseit
doesnothavesuﬃcientanalyticaldepthfor pYpeptides.Thusthe
use of both the pSTY peptide analysis strategy and the pY based
strategies is necessary to obtain a more complete view of the
pathway. Moreover, our results also show that the two pY based
strategies are highly complementary in identifying eﬀector pro-
teins. This justiﬁes the use of all three strategies in RTK signaling
studies to maximize coverage of the pathways.
An observation worth noting is that although the pY protein
strategy cannot provide information about speciﬁc phosphosites
and thus is often deemed inferior to the other two approaches,
our result shows that it is an eﬃcient approach for identiﬁcation
of eﬀector proteins. It identiﬁed more eﬀector proteins than the
pY peptide strategy (Figure 4B), and more eﬀector proteins that
are mapped to key associated pathways than both the other two
strategies. Among the three strategies, it has the unique ability to
identifyeﬀectorproteinsthatarephosphorylatedonsitesthatare
diﬃcult to be detected by MS.
For the analysis of EphB signaling, the use of all three
strategies signiﬁcantly increased the number of identiﬁed eﬀec-
tor/potential eﬀector proteins from 204 by one strategy (pY
protein analysis from a previous study
32) to 660. Moreover, this
study revealed hundreds of phosphosites that are regulated by
EphB receptor activation. This large pool of potential targets
generated by this study will facilitatefuture biological researchto
better understand the molecular basis of EphB signaling.
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